Associate Director, Field Reimbursement

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity:

This regionally aligned team (Northeast, Southeast, Central, and West) will manage the launch and ongoing lifecycle of Revolution Medicines’ approved therapies using a patient centric model.

This role requires a strategic team player with deep expertise in oncology market access, clinical knowledge, and a passion for ensuring no patient is left behind.

The Field Reimbursement Director (FRD) serves as key field-based expert in market access and the subject matter expert in navigating the reimbursement and access landscape for healthcare providers, office staff, and other critical stakeholders. This role provides education across the entire access journey, with deep expertise in prior authorization processes, coverage criteria, and payer-specific requirements across commercial, Medicare, and Medicaid plans.

This role requires strong business acumen, an understanding of the national payer environment, and the ability to build trusted relationships with provider offices, HUB services, Nurse Case Managers, specialty pharmacies, and internal cross-functional partners. The FRD ensures a positive customer experience by delivering clear guidance, resolving issues efficiently, and supporting timely and appropriate patient access to therapy.

Responsibilities:

• Proactively address patient access barriers by working with customers and accounts to resolve complex access issues, including prior authorizations, appeals, and denials. • Monitor and support resolution of access issues for hub-enrolled patients. • Educate private practices, Oncology groups/facilities, and their staff on patient support programs, coverage, and payer policies. • Accountable for ensuring access barriers are minimized, for appropriate patients, to obtain Revolution Medicines’ approved therapies. • Deliver clear and actionable information to practice managers, billing staff, nurses, and case workers to improve their understanding of payer policies and processes. • Report Payer trends related to approved products to Patient Services and Market Access account management teams. • Provide expertise within the national/regional Payer landscape to educate providers and office staff, on navigating the access process and payer trends. • Leverage market insights to anticipate customer needs and develop strategies that maintain a competitive edge. • Ensure that all activities and interactions adhere to relevant pharmaceutical regulations, industry standards, and ethical guidelines. • Maintain rigorous documentation standards to ensure access barriers are tracked, addressed, and compliantly resolved in alignment with a “no patient left behind” mindset. • Foster a culture grounded in patient advocacy, compassion, compliance, customer centricity, urgency, and collaboration. • Create and manage a “one-team” mindset with other critical access teams, including third-party hub provider, non-commercial pharmacy, third-party copay provider, RNCM Team, Medical, Quality Control, and Patient Access leadership. • Travel as needed to home office as applicable and external meetings and conferences. • Other duties as assigned.